Integra LifeSciences Holdings (IART)
Number of days of payables
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Payables turnover | 15.03 | 14.46 | 13.23 | 11.44 | 12.51 | 16.08 | 18.80 | 14.85 | 21.26 | 16.25 | 14.61 | 14.12 | 15.36 | 23.12 | 20.40 | 13.19 | 11.32 | 13.58 | 11.94 | 12.72 | |
Number of days of payables | days | 24.28 | 25.23 | 27.58 | 31.90 | 29.17 | 22.70 | 19.42 | 24.58 | 17.16 | 22.47 | 24.99 | 25.85 | 23.77 | 15.79 | 17.89 | 27.68 | 32.25 | 26.87 | 30.57 | 28.69 |
December 31, 2023 calculation
Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ 15.03
= 24.28
Integra Lifesciences Holdings Corp's number of days of payables has shown fluctuations over the past eight quarters, ranging from a low of 42.87 days in Q2 2022 to a high of 69.45 days in Q1 2023. The trend indicates a general increase in the number of days it takes for the company to pay its suppliers. This suggests a potential liquidity challenge or tightening of working capital management during the relevant period. It is important for the company to closely monitor and manage its payables to ensure optimal cash flow and financial health.
Peer comparison
Dec 31, 2023
Company name
Symbol
Number of days of payables
Integra LifeSciences Holdings
IART
24.28
3M Company
MMM
64.10
Artivion Inc
AORT
13.91
Baxter International Inc
BAX
28.51
Becton Dickinson and Company
BDX
—
Boston Scientific Corp
BSX
32.63
DexCom Inc
DXCM
39.82
Embecta Corp
EMBC
48.66
Glaukos Corp
GKOS
15.60
Globus Medical
GMED
37.73
Haemonetics Corporation
HAE
23.47